Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04623047 · ClinicalTrials.gov registry record
Infection Watch Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 10,034
- Enrollment target
NCT04623047 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 10,034 participants.
The verdict
NCT04623047 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 10,034 participants
- Enrollment target
Study Summary
This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respiratory Syncytial Virus. This study aims to develop a forecasting model to predict infection onset prior to symptom onset using wearable device data and known symptom onset and test dates.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,034 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2024-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04623047
The ClinicalTrials.gov registry entry for NCT04623047 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,034 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04623047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04623047 about?
NCT04623047 is a clinical study titled "Infection Watch Study". This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respiratory Syncytial Virus. This study aims to develop a forecasting model to predict infection onset pr...
What is the current status of trial NCT04623047?
This trial is currently completed. The enrollment target is 10,034 participants. The study started on 2023-06-28. Estimated completion is 2024-06-15.
Who is sponsoring clinical trial NCT04623047?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.